Multiple systems have been affected by COVID-19 infection, and neurological symptoms are not uncommon. A 45-year-old male presented to us in the emergency department without focal neurological deficits. He developed ascending paralysis soon after his admission, which was followed by worsening respiratory symptoms. The family of the patient refused a lumbar puncture, and his NCS/EMG showed features of acute motor axonal neuropathy (AMAN), a variant of Guillain-Barré syndrome (GBS). After being admitted on the 4th day, the patient developed type 2 respiratory failure and died on the 5th day of admission before any treatment could be started. Patients with COVID-19 may worsen their respiratory compromise due to a rare yet treatable neurological disease that should be addressed immediately to prevent complications and death.
Khan, Naveed Ullah; Hassan, Muhammad; Rajput, Haris Majid; Shahzad, Waleed; Mobeen, Hafsa; and Badshah, Mazhar
"Guillain–Barré Syndrome in Sars-Cov-2; A Case Report,"
Pakistan Journal of Neurological Sciences (PJNS): Vol. 16:
4, Article 6.
Available at: https://ecommons.aku.edu/pjns/vol16/iss4/6